🔎 Technical Overview
CarMax (NYSE: KMX) just suffered a brutal decline, dropping over 20% in a single session after posting weaker-than-expected Q2 results and issuing cautious guidance. On the 3-month chart, the stock shows a steep selloff, an RSI near 25 (oversold), and a MACD curling toward a bullish crossover, signaling potential for a short-term bounce.
On the 1-year chart, KMX hit fresh 52-week lows near $45, with RSI collapsing to 19.14, a rare oversold extreme. The MACD remains in bearish territory, confirming that momentum is still weak.
On the 5-year chart, the picture is more concerning: KMX is at levels not seen since the pandemic crash of 2020. RSI is oversold, but MACD has turned bearish again, reflecting a structural breakdown in trend.
➡️ Takeaway: Technically, KMX is very oversold and due for a relief rally, but longer-term charts remain fragile.
💰 Financial Snapshot
CarMax reported $27.79B in revenue (TTM) with net income of $521M, translating to razor-thin 1.88% net margins. Gross margin is only 11.35%, underscoring how competitive and cyclical the used-car space is.
- Debt-to-Equity: 3.09 → very high leverage.
- Free Cash Flow (TTM): $685M → positive, a rare strength.
- ROE: 8.42%, ROIC: 2.11% → below cost of capital, meaning limited value creation.
KMX trades at a P/E of 13.39 and a P/S ratio of 0.24, which looks cheap, but the debt load and thin margins justify the discount.
➡️ Takeaway: Fundamentally stable in cash flow, but debt and low margins cap upside.
📰 News Flow
The stock collapse was driven by Q2 earnings miss and cautious guidance, followed by multiple analyst downgrades. Law firms quickly announced “investigations,” which is common after steep selloffs.
- Motley Fool: Discussed whether the drop is a buying opportunity.
- Benzinga & TheFly: Analysts slashed targets to the $52–60 range.
- Evercore ISI: Downgraded to “In Line.”
➡️ Takeaway: Short-term sentiment is very bearish, but the oversold condition sets up for a relief rally if earnings stabilize.
📉 Analyst Targets
Recent revisions show drastic cuts:
- Needham: $92 → $60
- Baird: $90 → $60
- RBC Capital: $81 → $59
- Evercore ISI: $79 → $52
Consensus now sits around $58–60, implying ~30% upside from current $45 levels.
➡️ Analysts believe much of the downside is already priced in.
👥 Insider & Political Trading
- Executives: No recent open-market buys; one meaningful sale occurred near $70 pre-crash.
- House Disclosures: Congressman Ro Khanna has repeatedly bought KMX shares, most recently after the July 2025 decline. This shows contrarian confidence.
- Senate Disclosures: No meaningful recent activity.
➡️ Corporate insiders are neutral-to-bearish, while political insiders are modestly bullish.
🔮 Options Flow Analysis
Looking at call-side open interest across expirations:
- Oct/Nov 2025: Heavy OI around 47.5C and 57.5C → speculative bullish bets.
- Jan 2026: Strong OI clustering at 50C and 60C → traders expect recovery to ~$60.
- Jan 2027 LEAPS: Highest OI at 60C (413 contracts), delta ~0.44, vega ~0.20.
➡️ Options flow is skewing bullish, with traders betting on a rebound toward $50–60 by mid/late 2026.
🎯 LEAPS Strategy Setup
We will use the Jan 2027 $60 Calls (~474 DTE) for our structured entry:
- Delta: 0.44 → strong leverage, ~2.5x vs stock moves.
- Vega: 0.20 → excellent exposure to implied volatility.
- OI: Highest in the mid-range strikes, confirming liquidity.
- IV: ~45% → relatively cheap, giving room for IV expansion.
Catalyst Play
- Entering now positions us ahead of earnings-driven IV expansion.
- Plan is to close before earnings, when IV typically peaks.
- Profit target: +80% minimum, 100–110% stretch.
Risk Management
- Holding period: max 2 months. If gains do not materialize, roll into the next cycle.
- Not dependent on stock breaking $60 — gains come from delta + vega expansion.
📌 3-Batch Entry Plan
- Batch 1 – Enter Now: Buy Jan 2027 $60C.
- Batch 2 – Enter Later: If the options price drops -40% to -50%, scale in.
- Batch 3 – Enter Later: If the second batch’s options price drops -40% to -50%, scale in again.
(Important: This refers to the options price, not the stock price.)
⚠️ Disclaimer
This analysis is for informational and educational purposes only. Options involve substantial risk and are not suitable for all investors. You should never allocate more than 2% of your total portfolio to a single speculative options trade. The strategy outlined above carries risk of loss, and execution requires discipline, including rolling positions if profit targets are not met within the time window.
✅ Summary: CarMax is at multi-year lows, fundamentally pressured but technically oversold. Analyst targets and political insider buys suggest stabilization near $45–50, while options flow is aligning with a rebound into the $50–60 zone. By targeting Jan 2027 $60 LEAPS, we gain cheap vega exposure, which should expand into earnings. This is a well-structured short-horizon LEAPS volatility play, not a buy-and-hold trade.
